Remove Dosage Remove Pharmacy Management Remove Seminar
article thumbnail

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Pharmacy Times

1 "[Meloxicam injection] demonstrates our commitment to improving patient care by providing an alternate dosage form for pain management," Ron Scarboro, chief executive officer at Azurity Pharmaceuticals, said in a press release. Seminars in Arthritis and Rheumatism. PR Newswire. June 10, 2025. Accessed June 10, 2025.